Advicenne
Develops and commercializes therapies for rare renal diseases for patients of all ages.
ALDVI | PA
Overview
Corporate Details
- ISIN(s):
- FR0013296746 (+1 more)
- LEI:
- 969500YT5VMEYAYODW34
- Country:
- France
- Address:
- 262 RUE DU FAUBOURG SAINT-HONORE, 75008 PARIS
- Website:
- https://advicenne.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Advicenne is a specialty pharmaceutical company dedicated to developing, commercializing, and marketing innovative treatments for rare diseases. The company's primary focus is on improving the lives of patients with rare renal (nephrological) conditions. Leveraging more than a decade of research and development, Advicenne specializes in creating therapies suitable for both children and adults, underscoring its commitment to making groundbreaking treatments accessible to patients of all ages in international markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-07-28 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 164.8 KB | ||
| 2025-07-28 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 178.7 KB | ||
| 2025-07-25 07:30 |
Earnings Release
Inside Information / Other news releases
|
English | 177.4 KB | ||
| 2025-07-25 07:30 |
Earnings Release
Informations privilégiées / Autres communiqués
|
French | 190.6 KB | ||
| 2025-05-16 08:00 |
Post-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 114.8 KB | ||
| 2025-04-29 18:00 |
Registration Form
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
|
French | 182.1 KB | ||
| 2025-04-29 18:00 |
Registration Form
Annual financial and audit reports / Terms of availability of the annual financ…
|
English | 152.3 KB | ||
| 2025-03-27 19:12 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 324.3 KB | ||
| 2025-03-27 19:12 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 336.8 KB | ||
| 2025-01-23 18:30 |
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 233.9 KB | ||
| 2025-01-23 18:30 |
Earnings Release
Inside Information / Information on annual revenues
|
English | 243.6 KB | ||
| 2024-12-19 18:00 |
M&A Activity
Inside Information / Other news releases
|
English | 196.5 KB | ||
| 2024-12-19 18:00 |
M&A Activity
Informations privilégiées / Autres communiqués
|
French | 163.2 KB | ||
| 2024-11-28 18:00 |
Report Publication Announcement
Informations privilégiées / Autres communiqués
|
French | 192.1 KB | ||
| 2024-11-28 18:00 |
Report Publication Announcement
Inside Information / Other news releases
|
English | 190.8 KB |
Automate Your Workflow. Get a real-time feed of all Advicenne filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Advicenne via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-10-04 | N/A | Other | Other | 1,452,282 | 3,499,999.62 EUR |
| 2023-10-04 | N/A | Other | Buy | 41,493 | 99,998.13 EUR |
| 2023-10-02 | N/A | Other | Other | 414,937 | 999,998.17 EUR |
| 2023-09-21 | N/A | Other | Sell | 22,336 | 22.34 EUR |
| 2023-09-15 | N/A | Other | Sell | 134,492 | 13.45 EUR |
